Emily is a corporate Associate whose practice concentrates on licensing transactions, corporate and securities law, mergers and acquisitions, and general corporate matters. She works with public and private companies across a variety of industries, with a particular focus on life sciences. Emily originally joined Mintz as a Summer Associate.
Prior to working at Mintz, Emily gained hands-on experience as a law clerk at a biotechnology company, where she supported in-house counsel on a range of legal matters. Before transitioning to law, Emily worked in the life sciences industry for three years, holding roles in CMO management and research.
Emily earned her JD from Boston University School of Law, where she developed a strong foundation in corporate and transactional law. Before that, she graduated from Colby College, where she received a BA in chemistry and Spanish.
viewpoints
SEC Staff Issues Corporate Finance Interpretation (Formerly CD&I) Providing ATM Program Flexibility to S-3 Issuers Facing Baby Shelf Transition
March 27, 2026 | Alert | By Emily Dougherty, Jason S. McCaffrey
SEC CFI 116.26 confirms S-3 issuers can continue ATM sales after falling below $75M float if the prospectus supplement was filed before 10(a)(3).
News & Press
Mintz Advises Bollé Brands on the Sale of Its SPY+ and Serengeti Eyewear Brands to Safilo Group
July 08, 2026
Mintz advised Bollé Brands, an Alvarez & Marsal Capital portfolio company, on the sale of its SPY+ and Serengeti eyewear brands to Safilo Group, a global player in the eyewear industry.
Recent Insights
Mintz advised Bollé Brands, an Alvarez & Marsal Capital portfolio company, on the sale of its SPY+ and Serengeti eyewear brands to Safilo Group, a global player in the eyewear industry.
